These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8245538)
21. Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta. Merolla R; Rebert NA; Tsiviste PT; Hoffmann SP; Panuska JR Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1358-66. PubMed ID: 7551395 [TBL] [Abstract][Full Text] [Related]
22. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. Li XQ; Fu ZF; Alvarez R; Henderson C; Tripp RA J Virol; 2006 Jan; 80(1):537-40. PubMed ID: 16352577 [TBL] [Abstract][Full Text] [Related]
23. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes. Chang YC; Chow YH; Sun HL; Liu YF; Lee YT; Lue KH; Ko JL Antiviral Res; 2014 Oct; 110():124-31. PubMed ID: 25131377 [TBL] [Abstract][Full Text] [Related]
24. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice. Eichinger KM; Egaña L; Orend JG; Resetar E; Anderson KB; Patel R; Empey KM Respir Res; 2015 Oct; 16():122. PubMed ID: 26438053 [TBL] [Abstract][Full Text] [Related]
29. Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Garcia-Castillo V; Tomokiyo M; Raya Tonetti F; Islam MA; Takahashi H; Kitazawa H; Villena J Front Immunol; 2020; 11():568636. PubMed ID: 33133080 [TBL] [Abstract][Full Text] [Related]
31. Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV). Benoit A; Huang Y; Proctor J; Rowden G; Anderson R Clin Exp Immunol; 2006 Jul; 145(1):147-54. PubMed ID: 16792685 [TBL] [Abstract][Full Text] [Related]
32. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. Franke-Ullmann G; Pförtner C; Walter P; Steinmüller C; Lohmann-Matthes ML; Kobzik L; Freihorst J J Immunol; 1995 Jan; 154(1):268-80. PubMed ID: 7995946 [TBL] [Abstract][Full Text] [Related]
33. Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. Ebbert JO; Limper AH Respiration; 2005; 72(3):263-9. PubMed ID: 15942295 [TBL] [Abstract][Full Text] [Related]
34. Reduced Expression of HLA-DR on Monocytes During Severe Respiratory Syncytial Virus Infections. Ahout IM; Jans J; Haroutiounian L; Simonetti ER; van der Gaast-de Jongh C; Diavatopoulos DA; de Jonge MI; de Groot R; Ferwerda G Pediatr Infect Dis J; 2016 Mar; 35(3):e89-96. PubMed ID: 26658377 [TBL] [Abstract][Full Text] [Related]
35. Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons. Makris S; Bajorek M; Culley FJ; Goritzka M; Johansson C J Innate Immun; 2016; 8(5):452-63. PubMed ID: 27423203 [TBL] [Abstract][Full Text] [Related]
36. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease. Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451 [TBL] [Abstract][Full Text] [Related]
37. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection. Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232 [TBL] [Abstract][Full Text] [Related]